147 related articles for article (PubMed ID: 8097974)
1. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum.
Pu C; Vorhees CV
Brain Res Dev Brain Res; 1993 Apr; 72(2):325-8. PubMed ID: 8097974
[TBL] [Abstract][Full Text] [Related]
2. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
[TBL] [Abstract][Full Text] [Related]
3. Reduced degeneration of dopaminergic terminals and accentuated astrocyte activation by high dose methamphetamine administration in nociceptin receptor knock out mice.
Sakoori K; Murphy NP
Neurosci Lett; 2010 Jan; 469(3):309-13. PubMed ID: 20025929
[TBL] [Abstract][Full Text] [Related]
4. Time-course of methamphetamine-induced neurotoxicity in rat caudate-putamen after single-dose treatment.
Cappon GD; Pu C; Vorhees CV
Brain Res; 2000 Apr; 863(1-2):106-11. PubMed ID: 10773198
[TBL] [Abstract][Full Text] [Related]
5. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
6. Cellular basis for interactions between catecholaminergic afferents and neurons containing Leu-enkephalin-like immunoreactivity in rat caudate-putamen nuclei.
Pickel VM; Chan J; Sesack SR
J Neurosci Res; 1992 Feb; 31(2):212-30. PubMed ID: 1349353
[TBL] [Abstract][Full Text] [Related]
7. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.
Pu C; Fisher JE; Cappon GD; Vorhees CV
Brain Res; 1994 Jun; 649(1-2):217-24. PubMed ID: 7953636
[TBL] [Abstract][Full Text] [Related]
8. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural immunocytochemical localization of mu-opioid receptors in dendritic targets of dopaminergic terminals in the rat caudate-putamen nucleus.
Wang H; Moriwaki A; Wang JB; Uhl GR; Pickel VM
Neuroscience; 1997 Dec; 81(3):757-71. PubMed ID: 9316027
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine.
Pickel VM; Johnson E; Carson M; Chan J
Brain Res Dev Brain Res; 1992 Nov; 70(1):75-86. PubMed ID: 1361886
[TBL] [Abstract][Full Text] [Related]
11. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
[TBL] [Abstract][Full Text] [Related]
12. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.
Yu J; Wang J; Cadet JL; Angulo JA
Brain Res; 2004 May; 1007(1-2):124-31. PubMed ID: 15064143
[TBL] [Abstract][Full Text] [Related]
13. MK-801 prevents methamphetamine-induced striatal dopamine damage and reduces extracellular dopamine overflow.
O'Dell SJ; Weihmuller FB; Marshall JF
Ann N Y Acad Sci; 1992 May; 648():317-9. PubMed ID: 1637061
[No Abstract] [Full Text] [Related]
14. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study.
Pu C; Vorhees CV
Synapse; 1995 Feb; 19(2):97-104. PubMed ID: 7725247
[TBL] [Abstract][Full Text] [Related]
15. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.
Sarkar S; Gough B; Raymick J; Beaudoin MA; Ali SF; Virmani A; Binienda ZK
Neurosci Lett; 2015 Oct; 606():53-9. PubMed ID: 26321151
[TBL] [Abstract][Full Text] [Related]
16. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
Kogan FJ; Nichols WK; Gibb JW
Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
[TBL] [Abstract][Full Text] [Related]
17. A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein.
Fukumura M; Cappon GD; Pu C; Broening HW; Vorhees CV
Brain Res; 1998 Sep; 806(1):1-7. PubMed ID: 9739098
[TBL] [Abstract][Full Text] [Related]
18. Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke.
Jakab RL; Bowyer JF
Brain Res; 2002 Dec; 958(1):52-69. PubMed ID: 12468030
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
Schneider JS; Denaro FJ
J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
